The topical corticosteroid scalp treatment is expected to return to pharmacies in January 2020.
Following ongoing availability issues with the potent topical corticosteroid scalp treatment, Bettamousse 0.1% Cutaneous Foam (betamethasone valerate), the manufacturer, RPH Pharmaceuticals AB, contacted us with an update in December 2019.
RPH confirmed that there have been delays with the delivery of Bettamousse Foam, which they were due to receive near the end of November. According to this latest update Bettamousse is expected to return to stock in January 2020.
If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 0845 023 0467, or by email at firstname.lastname@example.org.
You can find more information about other currently unavailable treatments here